The natriuretic peptides in cardiovascular medicine

被引：126
|
作者：
Munagala, VK [1 ]
Burnett, JC [1 ]
Redfield, MM [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
CURRENT PROBLEMS IN CARDIOLOGY | 2004年 / 29卷 / 12期
关键词：
D O I：
10.1016/j.cpcardiol.2004.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Within the last five years, assay systems for measurement of plasma levels of brain natriuretic peptide (BNP) have been approved as a diagnostic aid for heart failure (HF). Similarly, nesiritide, a recombinant form of human BNP, has been approved for the treatment of acutely decompensated HE Both BNP as a diagnostic test and a therapeutic modality are rapidly becoming integrated into clinical practice. The purpose of this review is to provide a brief overview of the physiology of the natriuretic peptides relevant to their informed clinical use. The current literature regarding the utility of measuring BNP for the diagnosis and management of HF is reviewed and practical recommendations regarding the interpretation of BNP levels are offered. The clinical literature regarding the use of recombinant BNP for the treatment of HF is reviewed, underscoring current gaps in our knowledge regarding the indications for and benefits of this novel agent.
引用
收藏
页码：707 / 769
页数：63
相关论文
共 50 条
  • [31] Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases
    Lerner, Yana
    Hanout, Wessal
    Ben-Uliel, Shulamit Fluss
    Gani, Samar
    Leshem, Michal
    Qvit, Nir
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (32) : 2904 - 2921
  • [32] Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
    Daniels L.B.
    Current Cardiovascular Risk Reports, 2010, 4 (2) : 120 - 127
  • [33] Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1
    Bo Han
    Yonathan Hasin
    Cardiovascular Drugs and Therapy, 2003, 17 : 41 - 52
  • [34] Cardiac natriuretic peptides in plasma: from prediction to precision medicine
    Goetze, Jens P.
    Zois, Nora E.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10): : 803 - 805
  • [35] Natriuretic Peptides in Cardiovascular and Metabolic Crosstalk: Implications for Hypertension Management
    Jordan, Jens
    Birkenfeld, Andreas L.
    Melander, Olle
    Moro, Cedric
    HYPERTENSION, 2018, 72 (02) : 270 - 276
  • [36] Plasma B-Type Natriuretic Peptides in Children With Cardiovascular Diseases
    Das, Bibhuti B.
    PEDIATRIC CARDIOLOGY, 2010, 31 (08) : 1135 - 1145
  • [37] Aminoterminal natriuretic peptides and cardiovascular risk in an Italian male adult cohort
    Barbato, Antonio
    Sciarretta, Sebastiano
    Marchitti, Simona
    Iacone, Roberto
    Di Castro, Sara
    Stanzion, Rosita
    Cotugn, Maria
    Ippolito, Renato
    Palmieri, Luigi
    Calvieri, Camilla
    Battistoni, Allegra
    Volpe, Massimo
    Strazzullo, Pasquale
    Rubattu, Speranza
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 152 (02) : 245 - 246
  • [38] The role of natriuretic peptides in cardiovascular disorders and human cardiac allografts (Review)
    Ationu, A
    Boateng, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 2 (02) : 235 - 239
  • [39] Natriuretic Peptides as Predictors of Cardiovascular Events and All-Cause Mortality
    Alpert, Martin A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (05) : 572 - 574
  • [40] Brain natriuretic peptide: Disease marker or more in cardiovascular medicine?
    Doggrell, SA
    DRUGS OF TODAY, 2001, 37 (07) : 463 - 476
12345